$9.810
+0.163 (+1.66%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
BRCB Prediction & Forecast by Similar Chart Analysis
Alphio's BRCB stock price prediction model matches the current Black Rock Coffee Bar, Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $9.71 (-0.99%). The 1-week path is $10.00 (+1.91%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Black Rock Coffee Bar, Inc. Stock?
Black Rock Coffee Bar Inc (BRCB) is a good buy right now, trading at $9.81 with a strong recent performance of +21.56% over the last five days and a high RSI of 89.967 indicating strong momentum. The company has shown a positive trend in gross margin, reaching 45.88% in Q2 2026, which supports its profitability potential. However, the main risk is the high P/E ratio of 246.61, indicating that the stock may be overvalued relative to its earnings.
BRCB stock price ended at $9.81 on Friday, after rising +1.66%
Black Rock Coffee Bar, Inc. (BRCB) last closed at $9.81, gaining +1.66%. These facts feed the 1-day and 1-week BRCB price prediction above.
Forecast Drivers
Black Rock Coffee Bar, Inc. (BRCB) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches BRCB, ranked by similarity.
Seasonality analysis for BRCB
Historically the probability of a positive October return for BRCB is 57.50%. December offers the highest probability of a positive month at 100.00%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.